Product information & contact
Crespine Gel.
In Belgium.
Information for your practice, a treatment enquiry or an interest in distribution: find the right way to take your next step.
About Crespine Gel
Crespine Gel is an injectable cross-linked hyaluronic acid gel implant for the treatment of osteoarthritis joint pain. A physician administers it as a single 2 ml intra-articular injection.
Supply routes differ between countries. Use the form below and we will tell you how Crespine Gel can be obtained in Belgium, or put you in touch with the right contact there.
Regulatory framework in the European Union
As an EU member state, Belgium applies the European medical device rules directly. Crespine Gel carries the CE mark under Directive 93/42/EEC, conformity assessment under Annex II, issued by notified body CE Certiso Kft. (NB 2409). No separate national approval is required. Instructions for use must be supplied in the official language of the country of sale.
Manufactured by BioPolymer GmbH & Co. KG, Dümmer, Germany. Class III medical device. Quality management certified to ISO 13485:2016, certificate 145211-23-12-15. On the market since 2008.
Two variants
Crespine® Gel
Standard variant, without local anaesthetic.
Crespine® Gel +
Additionally contains the local anaesthetic prilocaine, released slowly from the hyaluronic acid matrix.
Which variant is appropriate is decided by the treating physician. Crespine Gel is not supplied directly to private individuals.
Send an enquiry
Contact us if you would like to obtain Crespine Gel in Belgium or find a treating physician. We will get back to you.